Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01437449
Title Weekly Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Stanford University

head and neck squamous cell carcinoma


Cetuximab + Cisplatin + Docetaxel


Age Groups: adult
Covered Countries USA

No variant requirements are available.